Skip to main content
Fig. 1 | BMC Neurology

Fig. 1

From: Efficacy and safety of cinepazide maleate injection in patients with acute ischemic stroke: a multicenter, randomized, double-blind, placebo-controlled trial

Fig. 1

Study design. Patients were assessed during the screening period and then on day 1 (baseline), day 7, and day 14 of the treatment period. After 14 days, patients entered a follow-up period for an additional 75 days and the study was completed on day 90 (±3 days). During the follow-up period, patients were assessed on days 30 and 90. D, day; V, visit

Back to article page